You are here
Confusion over which physicians, facilities, and pharmacies are in insurance companies’ networks has become an issue among enrollees in marketplace plans under health care reform, Medicare Advantage plans, and even accountable care organizations.
Once-daily, single-tablet regimens have become integral to the management of human immunodeficiency virus type 1 infection, partly because they may improve adherence due to a lower pill burden. This article reviews the single-tablet options.
When specially trained pharmacy technicians took patients’ medication histories in a hospital emergency department, the histories they conducted were accurate 88% of the time compared with 57% of those conducted by nurses, who had other duties.
Nonadherence contributes to poor attainment of treatment goals in type-2 diabetes mellitus; drug tolerability may play a part. Colesevelam, a second-generation bile acid resin, has improved tolerability and is associated with reductions in hemoglobin A1c.
Among the featured topics: oncolytic immunotherapy, BRAF/MEK inhibition, and a programmed death-1 inhibitor at the Society for Melanoma Research; and anticoagulation therapy, an alternative to statins, and endocarditis in the absence of dental antibiotic prophylaxis at the American Heart Association Scientific Sessions.
Multiple latent failures align to harm a patient seriously.
Hospitals can collect leftover narcotics—but will they?
FDA approvals, drug indications, and updates
Meningococcal group B vaccine (Trumenba) to prevent more types of invasive meningococcal disease; antihemophilic factor (recombinant), porcine sequence (Obizur) to treat bleeding from acquired hemophilia A; and pirfenidone (Esbriet) and nintedanib (Ofev) for idiopathic pulmonary fibrosis
Vortioxetine (Brintellix): a new serotonergic antidepressant